Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.
Martina RecaldeElena RoelAndrea PistilloAnthony G SenaAlbert Prats-UribeWaheed-Ul-Rahman AhmedHeba AlghoulThamir M AlshammariOsaid AlserCarlos Morgado AreiaEdward BurnPaula CasajustDalia DawoudScott L DuVallThomas FalconerSergio Fernández-BertolínAsieh GolozarMengchun GongLana Yin Hui LaiJennifer C E LaneKristine E LynchMichael E MathenyParas P MehtaDaniel R MoralesKarthik NatarjanFredrik NybergJose D PosadaChristian G ReichPeter R RijnbeekLisa M SchillingKarishma ShahNigam H ShahVignesh SubbianLin ZhangHong ZhuPatrick RyanDaniel Prieto-AlhambraKristin KostkaTalita Duarte-SallesPublished in: International journal of obesity (2005) (2021)
We show that PLWO differ from patients without obesity in a wide range of medical conditions and present with more severe forms of COVID-19, with higher hospitalization rates and intensive services requirements. These findings can help guiding preventive strategies of COVID-19 infection and complications and generating hypotheses for causal inference studies.
Keyphrases
- sars cov
- insulin resistance
- metabolic syndrome
- weight loss
- end stage renal disease
- healthcare
- type diabetes
- coronavirus disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- high fat diet induced
- weight gain
- primary care
- mental health
- patient reported outcomes
- skeletal muscle
- single cell
- adipose tissue
- body mass index
- patient reported
- respiratory syndrome coronavirus
- drug induced